VolitionRx Limited Schedules First Quarter 2026 Earnings Conference Call and Business Update
Rhea-AI Summary
VolitionRx (NYSE AMERICAN: VNRX) will host its first quarter 2026 earnings and business update conference call on Friday, May 15, 2026 at 8:30 a.m. U.S. Eastern Time (2:30 p.m. CET). Senior management will review financial and operating results, key events, and upcoming milestones, with live webcast and replay available.
Positive
- None.
Negative
- None.
News Market Reaction – VNRX
In the May 11 session, VNRX declined 8.89%, reflecting a notable negative market reaction. Argus tracked a peak move of +12.9% during that session. Argus tracked a trough of -4.2% from its starting point during tracking. Our momentum scanner triggered 17 alerts that day, indicating notable trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Conferences,earnings Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 25 | Earnings call scheduled | Neutral | +0.9% | Announced timing and access details for FY 2025 results call. |
| Nov 10 | Earnings call scheduled | Neutral | +0.6% | Scheduled Q3 2025 earnings and business update conference call. |
| Aug 08 | Earnings call scheduled | Neutral | +0.5% | Set date and time for Q2 2025 earnings and update call. |
| May 12 | Earnings call scheduled | Neutral | -1.0% | Announced Q1 2025 earnings call with management participation details. |
| Mar 25 | Earnings call scheduled | Neutral | +0.9% | Outlined logistics for FY 2024 earnings and business update call. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Scheduling earnings and business update calls has historically led to small, mostly positive price moves around the announcement.
Recent news shows VolitionRx advancing its platform and managing listing compliance, but share performance has been weak. Key items include acceptance of a NYSE American compliance plan on Apr 23, 2026, launch of the rNuQ™ webshop with 86% 2025 revenue growth, and full-year 2025 results with $1.7M revenue and reduced losses. Against this backdrop, the new Q1 2026 earnings call notice continues the established pattern of regular quarterly updates.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Conference call to take place on Friday, May 15 at 8:30 a.m.
Event: VolitionRx Limited First Quarter 2026 Earnings and Business Update Conference Call
Date: Friday, May 15, 2026
Time: 8:30 a.m.
Toll/International: 1-201-493-6779
Conference ID: 13760656
Louise Batchelor, Group Chief Marketing & Communications Officer of Volition will host the call along with Cameron Reynolds, President and Group Chief Executive Officer and Terig Hughes, Group Chief Financial Officer. The call will provide an update on important events that have taken place in the first quarter 2026, subsequent events and upcoming milestones.
A live audio webcast of the conference call will also be available on this link. In addition, a telephone replay of the call will be available until May 29, 2026. The replay dial-in numbers are 1-844-512-2921 (toll-free) in the
About Volition
Volition is a multi-national company focused on advancing the science of epigenetics. Volition is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, disease and treatment monitoring.
Through its subsidiaries, Volition is developing and commercializing simple, easy to use, cost-effective blood tests to help detect and monitor a range of diseases, including some cancers and diseases associated with NETosis, such as sepsis. Early detection and monitoring have the potential to not only prolong the life of patients, but also to improve their quality of life.
Volition's research and development activities are centered in
The contents found at Volition's website address are not incorporated by reference into this document and should not be considered part of this document. Such website address is included in this document as an inactive textual reference only.
Media Enquiries:
Louise Batchelor, Volition, mediarelations@volition.com +44 (0)7557 774620
View original content:https://www.prnewswire.com/news-releases/volitionrx-limited-schedules-first-quarter-2026-earnings-conference-call-and-business-update-302768143.html
SOURCE VolitionRx Limited